LY2157299 Monohydrate

galunisertib monohydrate · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2157299 Monohydrate, covering 2013-02-15 to 2019-12-09. Get the full timeline:

Most recent: Clinical Trial Update: LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer [Phase 2]